Translatome-based classification reveals a metabolic dependency of a new tumor subtype of pancreatic cancer.
Su‐Jin Shin(Yonsei University), Yvan Martineau(Centre National de la Recherche Scientifique), Carine Joffre(Inserm), Christine Jean(Centre National de la Recherche Scientifique), Stéphane Pyronnet(Centre National de la Recherche Scientifique), Juan Iovanna(Centre National de la Recherche Scientifique), Nelson Dusetti(Centre National de la Recherche Scientifique), Rémi Samain(Inserm), Mohamed Ayadi(La Ligue Contre le Cancer), Corinne Bousquet(Centre National de la Recherche Scientifique), Olle Larsson(Karolinska University Hospital), Rémy Nicolle(Centre National de la Recherche Scientifique)
Cited by 0
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions
|Nature Communications|2017|403
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter
|Proceedings of the National Academy of Sciences|1999|290
Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma
|The Journal of Pathology|2018|284